By Mandere Onyinkwa Kenya has received an initial consignment of 21,000 starter doses of the long-acting injectable HIV pre-exposure prophylaxis (PrEP), Lenacapavir. This marks the first phase of the country’s national rollout and underscoring its commitment to innovative, people-centred HIV prevention. Delivered in partnership with the Global Fund, the shipment is a major milestone as […]